{"id":"NCT02168946","sponsor":"Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)","briefTitle":"Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults","officialTitle":"A Phase 3, Multi-Center, Randomized, Open-Label Study of Vabomere(Meropenem-vaborbactam) Versus Best Available Therapy in Subjects With Selected Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae (CRE)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-07","primaryCompletion":"2017-07-21","completion":"2017-07-21","firstPosted":"2014-06-20","resultsPosted":"2018-12-11","lastUpdate":"2019-03-04"},"enrollment":77,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Urinary Tract Infection Complicated","Acute Pyelonephritis","Hospital Acquired Bacterial Pneumonia","Ventilator-associated Bacterial Pneumonia","Bacteremia","Abdominal Infection"],"interventions":[{"type":"DRUG","name":"Vabomere","otherNames":["Combination meropenem and vaborbactam","beta-lactamase inhibitor and carbapenem antibiotic"]},{"type":"DRUG","name":"Best Available Therapy","otherNames":["IV Antibiotics"]}],"arms":[{"label":"Vabomere","type":"EXPERIMENTAL"},{"label":"Best Available Therapy","type":"ACTIVE_COMPARATOR"}],"summary":"Vabomereâ„¢, (meropenem-vaborbactam) is being compared to the Best Available Therapy in the treatment of adults with selected serious infections due to Carbapenem Resistant Enterobacteriaceae","primaryOutcome":{"measure":"Proportion of Subjects in the Microbiological Carbapenem-resistant Enterobacteriaceae Modified Intent-to-Treat (mCRE-MITT) Population With a Response of Overall Success [Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) Subjects]","timeFrame":"at Test of Cure (TOC) visit (Day 12-23)","effectByArm":[{"arm":"Vabomere","deltaMin":4,"sd":null},{"arm":"Best Available Therapy","deltaMin":2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":null},"locations":{"siteCount":50,"countries":["United States","Argentina","Brazil","Colombia","Greece","Israel","Italy","United Kingdom"]},"refs":{"pmids":["33565042","30270406"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":17,"n":50},"commonTop":["Diarrhea","Anemia","Hypokalemia","Hypotension","Nausea"]}}